XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect Period of Adoption, Adjustment
Cumulative Effect Period of Adoption, Adjusted Balance
CRA International, Inc. Shareholders' Equity
CRA International, Inc. Shareholders' Equity
Cumulative Effect Period of Adoption, Adjustment
CRA International, Inc. Shareholders' Equity
Cumulative Effect Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect Period of Adoption, Adjusted Balance
Noncontrolling Interest
Noncontrolling Interest
Cumulative Effect Period of Adoption, Adjusted Balance
BALANCE at Dec. 30, 2017 $ 207,229   $ 207,595 $ 206,908   $ 207,274 $ 47,414 $ 47,414 $ 169,390   $ 169,756 $ (9,896) $ (9,896) $ 321 $ 321
BALANCE (ASC 606) at Dec. 30, 2017   $ 366     $ 366         $ 366          
BALANCE (in shares) at Dec. 30, 2017             8,297,172 8,297,172              
Increase (Decrease) in Shareholders' Equity                              
Net income 22,472     22,492         22,492         (20)  
Foreign currency translation adjustment (2,698)     (2,698)               (2,698)      
Exercise of stock options 2,166     2,166     $ 2,166                
Exercise of stock options (in shares)             100,771                
Share-based compensation expense for employees and non-employees 4,819     4,819     $ 4,819                
Restricted shares vesting (in shares)             237,509                
Redemption of vested employee restricted shares for tax withholding (3,946)     (3,946)     $ (3,946)                
Redemption of vested employee restricted shares for tax withholding (in shares)             (83,341)                
Shares repurchased (27,616)     (27,616)     $ (27,616)                
Shares repurchased (in shares)             (541,631)                
GNU gain on liquidation (258)                         (258)  
Distribution to noncontrolling interest (43)                         (43)  
Accrued dividends on unvested shares 21     21         21            
Cash paid on dividend equivalents (256)     (256)         (256)            
Cash dividends paid to shareholders (5,784)     (5,784)         (5,784)            
BALANCE at Dec. 29, 2018 196,472     196,472     $ 22,837   186,229     (12,594)   0  
BALANCE (in shares) at Dec. 29, 2018             8,010,480                
Increase (Decrease) in Shareholders' Equity                              
Net income 20,747     20,747         20,747            
Foreign currency translation adjustment 831     831               831      
Exercise of stock options 3,211     3,211     $ 3,211                
Exercise of stock options (in shares)             140,513                
Share-based compensation expense for employees 3,461     3,461     $ 3,461                
Restricted shares vesting (in shares)             128,089                
Redemption of vested employee restricted shares for tax withholding (2,176)     (2,176)     $ (2,176)                
Redemption of vested employee restricted shares for tax withholding (in shares)             (43,173)                
Shares repurchased (18,068)     (18,068)     $ (18,068)                
Shares repurchased (in shares)             (421,112)                
Accrued dividends on unvested shares 58     58         58            
Cash paid on dividend equivalents (246)     (246)         (246)            
Cash dividends paid to shareholders (6,539)     (6,539)         (6,539)            
BALANCE at Dec. 28, 2019 $ 197,751   $ 197,548 197,751   $ 197,548 $ 9,265 $ 9,265 200,249   $ 200,046 (11,763) $ (11,763) 0 $ 0
BALANCE (ASC 326) at Dec. 28, 2019   $ (203)     $ (203)         $ (203)          
BALANCE (in shares) at Dec. 28, 2019 7,814,797           7,814,797 7,814,797              
Increase (Decrease) in Shareholders' Equity                              
Net income $ 24,507     24,507         24,507            
Foreign currency translation adjustment 3,280     3,280               3,280      
Exercise of stock options 2,236     2,236     $ 2,236                
Exercise of stock options (in shares)             118,841                
Share-based compensation expense for employees 3,235     3,235     $ 3,235                
Restricted shares vesting (in shares)             61,396                
Redemption of vested employee restricted shares for tax withholding (862)     (862)     $ (862)                
Redemption of vested employee restricted shares for tax withholding (in shares)             (17,695)                
Shares repurchased (13,371)     (13,371)     $ (13,371)                
Shares repurchased (in shares)             (283,842)                
Accrued dividends on unvested shares (51)     (51)         (51)            
Cash paid on dividend equivalents (108)     (108)         (108)            
Cash dividends paid to shareholders (7,395)     (7,395)         (7,395)            
BALANCE at Jan. 02, 2021 $ 209,019     $ 209,019     $ 503   $ 216,999     $ (8,483)   $ 0  
BALANCE (in shares) at Jan. 02, 2021 7,693,497           7,693,497